Table 1 Current published data regarding SARS-CoV-2 detection in semen samples and the parameters used in the studies
|  | Li et al. 2020 (JAMA) | Pan et al. 2020 (F + S) | Holtmann et al. 2020 (F + S) | Song et al. 2020 (Biol Reprod) | Guo et al. 2020 (Andrology) | Kayaaslan et al. 2020 (Urol Int) | Rawlings et al. 2020 (OFID) | Ma et al. 2021 (J Med Virol) | Machado et al. 2021 (Infect Dis Rep) |
|---|---|---|---|---|---|---|---|---|---|
Location | Shangqiu, China | Wuhan, China | Duesseldorf, Germany | Wuhan, China | Wuhan, China | Ankara, Turkey | California, USA | Wuhan, China | Arkansas, USA |
Sample Size | 38 | 34 | 34 (18 with disease) | 13 (12 semen samples) | 23 | 16 | 6 | 12 | 15 |
Disease Type | Severe: 38 Positive Tests: Acute Stage: 4 Recovery Stage: 2 | Mild: 34 | Mild: 14 Moderate: 4 | Asymptomatic: 1 Mild: 11 | Mild: 18 Moderate: 5 | Mild: 11 Moderate: 5 | Unknown | Mild: 1 Moderate: 11 | Asymptomatic: 2 Mild to Moderate: 13 |
Method of Disease Confirmation | RT-PCR | RT-PCR | RT-PCR | RT-PCR | RT-PCR | RT-PCR | RT-PCR | RT-PCR | RT-PCR |
Detection in Semen? | 6/38 | 0/34 | 0/18 | 0/12 0/1 In Testis Sample | 0/23 | 0/16 | 0/6 | 0/12 | 1/15 |
Days after Diagnosis | 6–16 | 8–75 | 8–54 | Unknown | 27–33 | 0–7 | 6–17 | 56–109 | 0–14 |